ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Obituary: Eugene Schonfeld, Founder of Kidney Cancer Foundation

October 3, 1997

ARRA Funding Announcements Listed

April 10, 2009

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

Clearinghouse Members Names, First Meeting Scheduled For Nov. 8-9

September 24, 1976

Trials Approved by NCI CTEP Last Month

November 25, 2011